Anomalous Crossing Frequency in Odd Proton Nuclei

A generic explanation for the recently observed anomalous crossing frequencies in odd proton rare earth nuclei is given. As an example, the proton ${1\over 2} [541]$ band in $^{175}$Ta is discussed in detail by using the angular momentum projection theory. It is shown that the quadrupole pairing interaction is decisive in delaying the crossing point and the changes in crossing frequency along the isotope chain are due to the different neutron shell fillings

Gravitational Lensing at Millimeter Wavelengths

With today's millimeter and submillimeter instruments observers use gravitational lensing mostly as a tool to boost the sensitivity when observing distant objects. This is evident through the dominance of gravitationally lensed objects among those detected in CO rotational lines at z>1. It is also evident in the use of lensing magnification by galaxy clusters in order to reach faint submm/mm continuum sources. There are, however, a few cases where millimeter lines have been directly involved in understanding lensing configurations. Future mm/submm instruments, such as the ALMA interferometer, will have both the sensitivity and the angular resolution to allow detailed observations of gravitational lenses. The almost constant sensitivity to dust emission over the redshift range z=1-10 means that the likelihood for strong lensing of dust continuum sources is much higher than for optically selected sources. A large number of new strong lenses are therefore likely to be discovered with ALMA, allowing a direct assessment of cosmological parameters through lens statistics. Combined with an angular resolution <0.1", ALMA will also be efficient for probing the gravitational potential of galaxy clusters, where we will be able to study both the sources and the lenses themselves, free of obscuration and extinction corrections, derive rotation curves for the lenses, their orientation and, thus, greatly constrain lens models.Comment: 69 pages, Review on quasar lensing. Part of a LNP Topical Volume on "Dark matter and gravitational lensing", eds. F. Courbin, D. Minniti. To be published by Springer-Verlag 2002. Paper with full resolution figures can be found at ftp://oden.oso.chalmers.se/pub/tommy/mmviews.ps.g

Developing an Observing Air–Sea Interactions Strategy (OASIS) for the global ocean

The Observing Air–Sea Interactions Strategy (OASIS) is a new United Nations Decade of Ocean Science for Sustainable Development programme working to develop a practical, integrated approach for observing air–sea interactions globally for improved Earth system (including ecosystem) forecasts, CO2 uptake assessments called for by the Paris Agreement, and invaluable surface ocean information for decision makers. Our “Theory of Change” relies upon leveraged multi-disciplinary activities, partnerships, and capacity strengthening. Recommendations from >40 OceanObs’19 community papers and a series of workshops have been consolidated into three interlinked Grand Ideas for creating #1: a globally distributed network of mobile air–sea observing platforms built around an expanded array of long-term time-series stations; #2: a satellite network, with high spatial and temporal resolution, optimized for measuring air–sea fluxes; and #3: improved representation of air–sea coupling in a hierarchy of Earth system models. OASIS activities are organized across five Theme Teams: (1) Observing Network Design & Model Improvement; (2) Partnership & Capacity Strengthening; (3) UN Decade OASIS Actions; (4) Best Practices & Interoperability Experiments; and (5) Findable–Accessible–Interoperable–Reusable (FAIR) models, data, and OASIS products. Stakeholders, including researchers, are actively recruited to participate in Theme Teams to help promote a predicted, safe, clean, healthy, resilient, and productive ocean.publishedVersio

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Background: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 countries and territories and 811 additional subnational locations from 1950 to 2021, with a particular emphasis on changes in mortality and life expectancy that occurred during the 2020–21 COVID-19 pandemic period. Methods: 22 223 data sources from vital registration, sample registration, surveys, censuses, and other sources were used to estimate mortality, with a subset of these sources used exclusively to estimate excess mortality due to the COVID-19 pandemic. 2026 data sources were used for population estimation. Additional sources were used to estimate migration; the effects of the HIV epidemic; and demographic discontinuities due to conflicts, famines, natural disasters, and pandemics, which are used as inputs for estimating mortality and population. Spatiotemporal Gaussian process regression (ST-GPR) was used to generate under-5 mortality rates, which synthesised 30 763 location-years of vital registration and sample registration data, 1365 surveys and censuses, and 80 other sources. ST-GPR was also used to estimate adult mortality (between ages 15 and 59 years) based on information from 31 642 location-years of vital registration and sample registration data, 355 surveys and censuses, and 24 other sources. Estimates of child and adult mortality rates were then used to generate life tables with a relational model life table system. For countries with large HIV epidemics, life tables were adjusted using independent estimates of HIV-specific mortality generated via an epidemiological analysis of HIV prevalence surveys, antenatal clinic serosurveillance, and other data sources. Excess mortality due to the COVID-19 pandemic in 2020 and 2021 was determined by subtracting observed all-cause mortality (adjusted for late registration and mortality anomalies) from the mortality expected in the absence of the pandemic. Expected mortality was calculated based on historical trends using an ensemble of models. In location-years where all-cause mortality data were unavailable, we estimated excess mortality rates using a regression model with covariates pertaining to the pandemic. Population size was computed using a Bayesian hierarchical cohort component model. Life expectancy was calculated using age-specific mortality rates and standard demographic methods. Uncertainty intervals (UIs) were calculated for every metric using the 25th and 975th ordered values from a 1000-draw posterior distribution. Findings: Global all-cause mortality followed two distinct patterns over the study period: age-standardised mortality rates declined between 1950 and 2019 (a 62·8% [95% UI 60·5–65·1] decline), and increased during the COVID-19 pandemic period (2020–21; 5·1% [0·9–9·6] increase). In contrast with the overall reverse in mortality trends during the pandemic period, child mortality continued to decline, with 4·66 million (3·98–5·50) global deaths in children younger than 5 years in 2021 compared with 5·21 million (4·50–6·01) in 2019. An estimated 131 million (126–137) people died globally from all causes in 2020 and 2021 combined, of which 15·9 million (14·7–17·2) were due to the COVID-19 pandemic (measured by excess mortality, which includes deaths directly due to SARS-CoV-2 infection and those indirectly due to other social, economic, or behavioural changes associated with the pandemic). Excess mortality rates exceeded 150 deaths per 100 000 population during at least one year of the pandemic in 80 countries and territories, whereas 20 nations had a negative excess mortality rate in 2020 or 2021, indicating that all-cause mortality in these countries was lower during the pandemic than expected based on historical trends. Between 1950 and 2021, global life expectancy at birth increased by 22·7 years (20·8–24·8), from 49·0 years (46·7–51·3) to 71·7 years (70·9–72·5). Global life expectancy at birth declined by 1·6 years (1·0–2·2) between 2019 and 2021, reversing historical trends. An increase in life expectancy was only observed in 32 (15·7%) of 204 countries and territories between 2019 and 2021. The global population reached 7·89 billion (7·67–8·13) people in 2021, by which time 56 of 204 countries and territories had peaked and subsequently populations have declined. The largest proportion of population growth between 2020 and 2021 was in sub-Saharan Africa (39·5% [28·4–52·7]) and south Asia (26·3% [9·0–44·7]). From 2000 to 2021, the ratio of the population aged 65 years and older to the population aged younger than 15 years increased in 188 (92·2%) of 204 nations. Interpretation: Global adult mortality rates markedly increased during the COVID-19 pandemic in 2020 and 2021, reversing past decreasing trends, while child mortality rates continued to decline, albeit more slowly than in earlier years. Although COVID-19 had a substantial impact on many demographic indicators during the first 2 years of the pandemic, overall global health progress over the 72 years evaluated has been profound, with considerable improvements in mortality and life expectancy. Additionally, we observed a deceleration of global population growth since 2017, despite steady or increasing growth in lower-income countries, combined with a continued global shift of population age structures towards older ages. These demographic changes will likely present future challenges to health systems, economies, and societies. The comprehensive demographic estimates reported here will enable researchers, policy makers, health practitioners, and other key stakeholders to better understand and address the profound changes that have occurred in the global health landscape following the first 2 years of the COVID-19 pandemic, and longer-term trends beyond the pandemic. Funding: Bill & Melinda Gates Foundation

Coral reefs of the turbid inner-shelf of the Great Barrier Reef, Australia: an environmental and geomorphic perspective on their occurrence, composition and growth

Investigations of the geomorphic and sedimentary context in which turbid zone reefs exist, both in the modern and fossil reef record, can inform key ecological debates regarding species tolerances and adaptability to elevated turbidity and sedimentation. Furthermore, these investigations can address critical geological and palaeoecological questions surrounding longer-term coral-sediment interactions and reef growth histories. Here we review current knowledge about turbid zone reefs from the inner-shelf regions of the Great Barrier Reef (GBR) in Australia to consider these issues and to evaluate reef growth in the period prior to and post European settlement. We also consider the future prospects of these reefs under reported changing water quality regimes. Turbid zone reefs on the GBR are relatively well known compared to those in other reef regions. They occur within 20 km of the mainland coast where reef development may be influenced by continual or episodic terrigenous sediment inputs, fluctuating salinities (24-36 ppt), and reduced water quality through increased nutrient and pollutant delivery from urban and agricultural runoff. Individually, and in synergy, these environmental conditions are widely viewed as unfavourable for sustained and vigorous coral reef growth, and thus these reefs are widely perceived as marginal compared to clear water reef systems. However, recent research has revealed that this view is misleading, and that in fact many turbid zone reefs in this region are resilient, exhibit relatively high live coral cover (>30%) and have distinctive community assemblages dominated by fast growing (Acropora, Montipora) and/or sediment tolerant species (Turbinaria, Goniopora, Galaxea, Porites). Palaeoecological reconstructions based on the analysis of reef cores show that community assemblages are relatively stable at millennial timescales, and that many reefs are actively accreting (average 2-7 mm/year) where accommodation space is available, despite recent anthropogenic pressures. These turbid zone reefs challenge traditional views on the environmental conditions required for active reef growth, but given their proximity to land and associated stresses, current knowledge on these less well understood reefs should be synthesised to aid coastal management directives. Terrigenous sediments are a dominant influence on turbid zone reef occurrence, composition and growth, and, therefore, the assessment of their future prospects will require a detailed understanding of the sedimentary regimes under which they occur and of their differential response modes

Carbonate and terrigenous sediment budgets for two inshore turbid reefs on the central Great Barrier Reef

Inshore turbid zone reefs on the Great Barrier Reef (GBR) occur within 20 km of the mainland coast under marine environmental conditions (with respect to sedimentation rates, turbidity and water quality) that are generally considered marginal for reef growth. Despite this, data from various benthic habitat assessments report high (>30%) coral cover in these environments and reef core records show them to be characterised by relatively rapid rates of vertical accretion (2-8 mm/year), a long-term trend indicative of high net carbonate productivity and in-situ carbonate framework accumulation. However, the lack of quantitative data on terrigenous sediment input and flux rates, and on carbonate production rates has inhibited understanding of both ecological timescale rates of carbonate production and the aggregated long-term net impacts of sediments on reef growth. To address this knowledge gap a modem carbonate budget and terrigenous sediment model, that quantified allochthonous sediment inputs onto, within and off reef, was developed at two inshore reefs: Middle Reef and Paluma Shoals. Both are located within the central region of the GBR and are subjected to high terrigenous sediment load (>11,000 tonnes/year) and fluctuating turbidity (5 to >100 mg/L) regimes. Based on sediment dynamic modelling, over 81% of sediments delivered were transported off reef, with net sediment accumulation limited to sheltered reef habitats. Net carbonate production was high (>6.9 kg/m²/year) due to high coral cover (>30%), high coral calcification rates (Acropora average 63 g/cm²/year), and low bioerosion rates (0.3 to 5 kg/m²/year), but varied spatially with highest net carbonate production (>10 kg/m²/year) within deep (>-2 m at LAT) windward reef zones. High carbonate framework production has enabled Middle Reef and Paluma Shoals to vertically accrete rapidly: Middle Reef establishing at depths of-4 m, Paluma Shoals at -3 m depth and both reaching sea level in <1200 years. Carbonate and terrigenous sediment inputs were used to develop a reef growth model with time and depth that illustrates how rates and modes of reef growth varied temporally as the reefs approached sea level. Both Middle Reef and Paluma Shoals are still actively accreting, although vertical reef growth potential is increasingly constrained as the reef flats infill at present sea level